• banner
  • banner
  • banner

"Discover cutting-edge CAR T-Cell therapy, TIL therapy and groundbreaking clinical trials for innovative cancer treatment. Join us in fighting cancer today!"

"Through innovative solutions and unwavering dedication, we strive to eliminate barriers, provide hope, and contribute to a world where cancer is not just treatable but conquerable".

CAR T-Cell therapy, Clinical trials and Treatment abroad

Card image cap

Cell Therapies

CancerFax is a pioneering platform dedicated to connecting individuals facing late-stage cancers with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide. By leveraging cutting-edge technology and an extensive global network of medical institutions. This life-saving service empowers patients to explore new frontiers in cancer treatment while providing them with comprehensive information on trial eligibility criteria, locations, and enrollment processes.

Card image cap

Treatment Abroad

CancerFax is the most trusted international patient facilitator, working with top cancer hospitals in the world like MD Anderson, Dana Farber, Mayo Clinic, Parkway Singapore, Asan, Sheba, NCC Japan, Beijing Cancer Institute, Apollo, and BLK Max to bring you the best and latest drugs and therapies. Our team ensures patients get bespoke end-to-end services for cancer treatment abroad in the USA, Japan, South Korea, Israel, China, and India.


Check details on cancer treatment abroad.

Card image cap

Clinical Trials

Our company specializes in cancer clinical trial services, facilitating access to groundbreaking research and treatment options. We connect patients with cutting-edge trials, fostering hope and progress in the fight against cancer. With a commitment to improving lives, we’re at the forefront of advancing cancer care through clinical innovation.


Check details on cancer clinical trials.

"I am profoundly grateful for the support and guidance I received when I visited the USA for cancer clinical trials. The team behind this endeavor demonstrated an unwavering commitment to my well-being and a deep understanding of the complexities of medical research. Their expertise and dedication not only gave me access to cutting-edge treatments but also instilled hope and optimism during a challenging time. Truly, a remarkable team making a difference!"

Allam Lim
Leukemia Cancer Survivor, Philippines

Clinical trials

CancerFax specializes in guiding individuals through the complex process of enrolling in cancer clinical trials. With unwavering dedication, we connect patients to cutting-edge research and treatment options, offering a lifeline of hope in their battle against cancer.

Our team of compassionate experts navigates the intricate world of clinical trials, ensuring that every patient receives personalized support and guidance. We’re committed to empowering patients, giving them access to innovative therapies, and advancing the fight against cancer. At our company, we believe that participation in clinical trials can be a vital step towards a brighter future.


Check details on cancer clinical trials.

CAR T-Cell Therapy

CAR T Cell therapy is a revolutionary immunotherapy approach that offers new hope in the fight against cancer. CAR, which stands for Chimeric Antigen Receptor, is a synthetic receptor engineered into a patient’s T cells, the body’s natural defense against diseases. These modified CAR T cells are designed to recognize and attack specific cancer cells with precision, sparing healthy tissues. CAR T cell therapy has shown remarkable success, particularly in treating certain types of leukemia and lymphoma, leading to remissions and improved survival rates in some cases.

Despite challenges such as potential side effects and high costs, ongoing research aims to expand its application to a broader range of cancers, promising a brighter future in the battle against this formidable disease.


Check details on CAR T-Cell therapy.

"CAR T cell therapy was my lifeline. After years of battling cancer, this treatment brought a miraculous turnaround. It felt like my own cells became fearless cancer warriors. Today, I'm living proof that science and hope can conquer even the toughest fights. Thank you, CAR T cell therapy."

Daljeet Singh
Non-Hodgkin Lymphoma Survivor, India

"I am immensely grateful for the exceptional lung cancer treatment I received in the USA. The dedicated medical team, state-of-the-art facilities, and innovative therapies gave me hope and a second chance at life. Their compassionate care and expertise made all the difference in my journey to recovery."

Nowak Kowalska
Lung cancer survivor, Polland

Cancer treatment in the USA

In the USA, cutting-edge cancer care is a wonderful synthesis of innovation, research, and all-encompassing care. Top cancer hospitals in the USA use cutting-edge technology like immunotherapy and precision medicine to customize therapies for each patient’s particular genetic composition and cancer kind. This tailored strategy has produced better results and fewer negative effects. Clinical trials are also easily accessible, giving patients access to innovative treatments that show promise for the future. However, the high expense of cancer treatment continues to be a problem, sparking continuous discussions about access to and affordability of healthcare.

Cancer patients and their families continue to have hope because to the USA’s dedication to breaking new ground in cancer therapy.


Check details on cancer treatment in the USA.

Cancer treatment in India

Cancer treatment in India has made significant strides, offering advanced therapies such as surgery, chemotherapy, radiation, and immunotherapy. Top cancer hospitals in India like Tata Memorial Centre, Apollo cancer hospital, BLK, Artemis, Asian Oncology, American Oncology, HCG etc. provide world-class care.

India’s advantage lies in affordability, attracting medical tourists seeking high-quality, cost-effective cancer treatments.


Check details on cancer treatment in India.

“I visited India for my breast cancer treatment. I completed my surgery, chemotherapy and radiation therapy in just $ 8500 USD. Now I am free from cancer. I can say that India has the best and most economical cancer treatment."

Amanda Ncube
Breast Cancer Survivor, Zimbabwe

"I can't thank Parkway Cancer Centre enough for their unwavering support and exceptional care during my battle with liver cancer. The entire team, from oncologists to nurses, treated me with compassion and expertise. Their cutting-edge treatments and personalized approach played a pivotal role in my successful recovery."

Mohammad Nazakat Khan
Liver cancer survivor, Pakistan

Cancer treatment in Singapore

Cancer treatment in Singapore is characterized by cutting-edge medical technology and a holistic approach to care. World-class facilities like the Parkway Cancer Center provide a comprehensive range of treatments, from surgery and chemotherapy to targeted therapies and immunotherapy. Multidisciplinary teams of experienced oncologists tailor personalized treatment plans, ensuring the best outcomes for patients. Singapore’s healthcare system is known for its efficiency and accessibility, attracting patients from around the world.

Beyond medical care, the country offers a supportive environment for patients and their families, with numerous support groups and counseling services to help navigate the challenging journey of cancer treatment.


Check details on cancer treatment in Singapore.

Cancer treatment in South-Korea

Cancer treatment in South Korea is characterized by a harmonious blend of traditional and modern approaches to healthcare. Leading medical institutions like the National Cancer Center Korea and Asan Medical Center offer state-of-the-art technology and a holistic patient-centric approach. South Korea’s healthcare system is renowned for its efficiency, accessibility, and quality of care, attracting patients from across the globe.

The country boasts a thriving medical tourism industry, offering advanced treatments such as precision medicine and immunotherapy. Patients benefit not only from cutting-edge therapies but also from a supportive ecosystem of research, clinical trials, and comprehensive cancer care services.


Check details on cancer treatment in South-Korea.

"Words cannot express my gratitude to Asan Medical Center for their exceptional care during my battle with blood cancer. Their skilled team of hematologists and nurses combined expertise with unwavering support, guiding me through a challenging journey. Asan's commitment to cutting-edge treatments, including stem cell transplantation, was pivotal in my successful recovery. Beyond medical excellence, their genuine compassion and personalized care made all the difference. I am a proud survivor today because of Asan Medical Center's dedication to eradicating blood cancers."

Mohsin Ibrahimi
Blood cancer survivor, Iran

"As a lung cancer survivor, I owe my second chance at life to your exceptional care and expertise. Your dedicated team of oncologists and nurses showed unwavering support throughout my journey. Sheba's commitment to research and innovation shines brightly, offering hope to patients like me. Thank you for giving me my life back."

Albert Steve
Lung cancer survivor, Nigeria

Cancer treatment in Israel

Cancer treatment in Israel stands at the forefront of medical innovation. Renowned for its advanced research and pioneering therapies, Israel’s healthcare system offers world-class oncology care. Leading institutions like Sheba Medical Center and Hadassah Hospital leverage state-of-the-art technology, precision medicine, and immunotherapy to combat cancer effectively.

Israel’s collaborative environment encourages groundbreaking research and clinical trials, making it a hub for innovation in oncology. Additionally, a compassionate and multidisciplinary approach ensures holistic patient care, while medical tourists seek its expertise. Israel’s commitment to cancer treatment extends beyond borders, offering hope and advanced solutions to patients worldwide.

CAR T-Cell therapy in India

India’s innovative CAR-T cell therapy, NexCAR19, is the country’s initial indigenous strategy to fight cancer. Created by ImmunoACT, a branch of IIT Bombay, this advanced therapy utilizes genetically modified T-cells to target and eliminate cancerous cells, specifically in blood malignancies such as leukemia and lymphomas. Initial trials demonstrate potential, with around 50% obtaining total remission, particularly in juvenile cases of B-cell acute lymphoblastic leukemia.


NexCAR19 shows decreased neurotoxicity in comparison to foreign options, indicating possible benefits over current treatments. India plans to provide this treatment at a reduced cost compared to worldwide prices, starting at roughly INR 30–40 lakhs and aiming to lower it to INR 10–20 lakhs with regulatory approval.


Check out details on CAR T-Cell therapy in India.

“Over the past four years, we have gained unique expertise in accessing the patient medical condition and choosing the right treatment and clinical trial."

Huang Lin
Patient Care Manager, CancerFax - China

“I am writing this testimonial to express my profound gratitude for the life-changing experience I had with CAR T-cell therapy in China. My journey battling cancer took a hopeful turn when I was introduced to this groundbreaking treatment, and it has been nothing short of remarkable. Before CAR T-cell therapy, I had exhausted conventional treatments without much success. My situation was dire, and hope was fading. However, my decision to undergo CAR T-cell therapy in China was a turning point. The level of care and expertise I received was exceptional. The medical team was not only highly skilled but also incredibly compassionate, providing me with the support and reassurance I needed during this challenging time..”

Bjorn Simenson
Multiple Myeloma Survivor, Norway

CAR T-Cell therapy in China

CAR T-cell therapy in China has seen remarkable advancements in recent years, mirroring the global progress in this cutting-edge cancer treatment. With more than 700 ongoing clinical trials, China leads the development of CAR T-Cell therapy. China has swiftly embraced CAR T-cell therapy, offering new hope to patients battling various cancers, including leukemia and lymphoma. Several Chinese hospitals and research institutions are actively conducting clinical trials and providing CAR T-cell therapy to eligible patients.

The country’s robust infrastructure and access to a vast patient population have accelerated research and development efforts. With a commitment to advancing this innovative therapy, China is significantly contributing to the global landscape of cancer immunotherapy, enhancing treatment options for patients nationwide.


Check details on CAR T-Cell therapy in China.

CAR T-Cell therapy in Israel

In Israel, CAR T-cell therapy has emerged as a transformative approach in the fight against cancer. The country’s healthcare sector, known for its world-class research and innovation, has made significant strides in developing and implementing CAR T-cell therapies for patients with hematologic malignancies and solid tumors.

Leading medical institutions and biotechnology companies in Israel are actively involved in clinical trials and research projects, pushing the boundaries of CAR T-cell therapy. Israel’s collaborative environment and cutting-edge technologies have positioned it as a global player in advancing immunotherapy, offering new treatment avenues and hope for cancer patients, both domestically and worldwide.


Check details on CAR T-Cell therapy in Israel.

Once I arrived at Sheba, I realized that I had come to the right place. All the documents were processed within ten days, and the whole process was swift and simple. My doctor was Prof. Nagler, and Prof. Avraham Avigdor accompanied him. I had a positive impression of them; everything was clear and calm. Like me, my coordinator, Vika, is also from Kyiv, so we quickly developed a rapport. The nurses and medical staff are just great. Very warm and friendly. Most importantly, the procedure itself went smoothly, with no complications.”

Marina Oksana
Non-Hodgkin Lymphoma Survivor - Ukraine

“I want to extend my heartfelt appreciation to the dedicated medical professionals and researchers in Singapore who are pioneering this revolutionary therapy. To anyone considering CAR T-cell therapy, I wholeheartedly encourage you to explore this option. It has been a life-altering journey for me, and I hope it can bring the same hope and healing to others.”

Mitchell Kerp
Lymphoma Survivor, New Zealand

CAR T-Cell therapy in Singapore

CAR T-cell therapy has made significant inroads in Singapore’s healthcare landscape, offering a promising avenue for cancer treatment. The country’s advanced medical infrastructure and research capabilities have enabled the development and application of this cutting-edge immunotherapy.

Patients in Singapore now have access to CAR T-cell therapy for various blood cancers, marking a transformative shift in oncology care. Local healthcare institutions are actively involved in clinical trials and collaborations with global experts, ensuring patients receive world-class treatment. With its commitment to innovation and patient-centric care, Singapore is playing a pivotal role in advancing CAR T-cell therapy, providing new hope to cancer patients in the region and beyond.

Check details on CAR T-Cell therapy in Singapore.

FUCASO treatment for multiple myeloma

China’s National Medical Products Administration (NMPA) recently approved a new BCMA CAR T cell therapy for cancer in China called FUCASO, marking a potential turning point in the fight against this complex disease. So, what is multiple myeloma, and why is FUCASO creating such excitement?

Recent studies show remarkable promise during trials, with an overall response rate of 96% and a complete response rate of 74.3% observed in 103 enrolled patients. This blog dives deeper into the science behind FUCASO, its potential impact on myeloma patients, and the hope it brings to the global fight against this challenging disease.

Read more about FUCASO treatment for multiple myeloma in China.


Recent studies show remarkable promise during trials, with an overall response rate of 96% and a complete response rate of 74.3% observed in 103 enrolled patients. This blog dives deeper into the science behind FUCASO, its potential impact on myeloma patients, and the hope it brings to the global fight against this challenging disease.

Li C, Wang D, Song Y, et al.
Innovent and IASO Bio

"I am honored to be a part of CancerFax, a compassionate and dedicated organization that truly makes a difference in the lives of cancer patients. The commitment to patient care and support here is unparalleled. I am proud to work alongside such a caring and talented team, and I look forward to continuing our mission of providing comfort and hope to those battling cancer."

Albert Chen
Country Lead - China & Hong Kong

CancerFax: Empowering Lives, Transforming Journeys

Our vision is to lead the way in revolutionizing cancer treatment facilitation, ensuring every individual’s access to personalized, comprehensive, and compassionate care. Through innovative solutions and unwavering dedication, we strive to eliminate barriers, provide hope, and contribute to a world where cancer is not just treatable but conquerable.


Mission Statement

“Through innovative solutions and unwavering dedication, we strive to eliminate barriers, provide hope, and contribute to a world where cancer is not just treatable but conquerable.”


We are committed to:


  1. Personalized Pathways: Tailoring treatment options to each patient’s unique needs.
  2. Global Network: Building a global network of renowned oncologists, cutting-edge treatment centers, and support services.
  3. Empowerment Through Knowledge: Providing comprehensive, up-to-date information.
  4. Compassionate Support: Offering emotional and practical support.
  5. Innovation and Research: Collaborating with leading research institutions.
  6. Advocacy and Awareness: Advocating for improved cancer care policies.
  7. Ethical Excellence: Upholding the highest ethical standards.

Check details on how are we making an impact.

What doctors say about us?

“I want to extend my heartfelt appreciation for the invaluable services provided by CancerFax to our cancer patients. As a doctor, I am deeply impressed by the dedication, professionalism, and expertise exhibited by your team. Your company plays a pivotal role in connecting our patients with vital clinical trials and cutting-edge treatments, enhancing their prospects for recovery. Your commitment to personalized care and unwavering support has not only benefited our patients but has also made a significant contribution to advancing cancer research. I am proud to collaborate with CancerFax, as you continue to be a beacon of hope for those facing this challenging journey.”



Dr Jonathan Goldman

Medical Oncologist - UCLA Cancer Center, California, USA

Frequently asked questions.

Find below answers for the most common patients questions.

Online cancer consultation refers to the process of obtaining medical advice, a diagnosis, and treatment recommendations for cancer-related issues via virtual platforms. It enables patients to communicate remotely with oncologists and other healthcare professionals via video calls and telemedicine technology. Online consultations offer convenience and accessibility, especially for those with mobility issues or who reside in remote areas.

Using telemedicine technology, online cancer consultations connect patients and healthcare professionals remotely. Patients can discuss their cancer-related concerns, share medical records, and obtain expert advice via secure video calls or teleconferencing platforms. Doctors can examine the provided information remotely and provide a diagnosis, treatment recommendations, and ongoing support. If need be, specialists can also connect with local treating doctors to formulate a treatment plan that is most suitable for the patient.

CancerFax is connected to some of the world’s and the USA’s top cancer hospitals. Check our list of hospitals above and select the one that fits your requirements. Our medical team can also help you select the one that fits your requirements and needs. Check out the list of the best cancer hospitals in the USA.

You need to provide the following medical records:

  1. Medical summary
  2. Latest PET CT scan
  3. Latest blood reports
  4. Biopsy report
  5. Bone marrow biopsy (For blood cancer patients)
  6. All the scans in DICOM format

Apart from this you also need to sign the patient consent form provided by CancerFax.

Yes, you get a prescription and a complete report / protocol on the course of treatment required.

You do not need any equipment for an online consultation; you just need a pathology consultation and a written report. For video and telephonic consultations, you will need a smart phone with good internet speed.

CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative immunotherapy approach. It involves collecting a patient’s own T cells, genetically modifying them to target cancer cells more effectively, and then infusing these modified cells back into the patient’s body. The CAR T cells can recognize and attack cancer cells with precision. Check out the complete details on CAR T-Cell therapy.

Eligibility for CAR T-cell therapy depends on various factors, including the type of cancer, its stage, and the patient’s overall health. Typically, CAR T-cell therapy is considered for patients with certain types of relapsed or refractory blood cancers, such as leukemia or lymphoma, who have not responded to standard treatments. Your oncologist will assess your specific case to determine eligibility.

CAR T-cell therapy can have side effects, including cytokine release syndrome (CRS) and neurologic side effects. CRS can cause fever, flu-like symptoms, and, in severe cases, organ dysfunction. Neurologic side effects may include confusion or seizures. Healthcare professionals are closely monitoring and managing these side effects. It’s essential to discuss potential risks and benefits with your medical team.

A clinical trial is a research study designed to test new treatments or interventions for cancer. By participating, you may receive access to cutting-edge therapies that could potentially be more effective than standard treatments. Clinical trials also contribute to advancing medical knowledge and improving future cancer care.

You can start by discussing clinical trial options with your oncologist or healthcare provider. They can recommend trials based on your specific cancer type, stage, and medical history. Additionally, websites like ClinicalTrials.gov and patient advocacy organizations often provide searchable databases of ongoing trials.

Benefits may include access to innovative treatments, close medical monitoring, and potentially improved outcomes. Risks can vary but may include side effects from experimental treatments or the chance that the new treatment doesn’t work as well as standard care. It’s important to thoroughly discuss both risks and benefits with your healthcare team before making a decision.

Not all clinical trials use placebos, and many involve comparing the experimental treatment to the current standard of care. If a placebo is used, participants are informed beforehand, and ethical guidelines ensure that no one is denied necessary treatment. Your healthcare team will explain the trial design and whether a placebo is involved.

Clinical trials are conducted with a strong emphasis on patient safety. Ethics committees and regulatory organizations closely monitor them and enforce strict protocols. You will be informed about potential risks and monitored throughout the trial. You can withdraw from a trial at any time if you have concerns about safety or other issues.

Typically, the clinical trial sponsor is responsible for covering the costs of the experimental treatment and study-related tests. However, you may still be responsible for standard medical expenses not related to the trial, such as regular doctor visits or non-experimental treatments. It’s essential to discuss financial aspects with the trial coordinator and your insurance provider to understand what is covered and any potential out-of-pocket expenses. Many insurance plans now cover the routine costs of clinical trial participation.

CAR T-cell therapy is typically a one-time treatment. However, some patients may require additional infusions or other treatments if their cancer relapses or if there’s a need for long-term follow-up care. Your treatment plan will be tailored to your specific situation.

After CAR T-cell therapy, you will be closely monitored for potential side effects and to assess the treatment’s effectiveness. Success rates can vary depending on the type and stage of cancer. CAR T-cell therapy has shown promising results in some patients with relapsed or refractory blood cancers, leading to complete remissions. However, individual responses may vary, and it’s essential to discuss your prognosis with your medical team.

Yes, some companies have started CAR T-Cell therapy in India with the help of vectors from China and Malaysia. However, this therapy is still under clinical trials. Patient consent forms and doctor advice are solicited before you go for these trials.

The cost of CAR T-cell therapy varies from country to country. Here is the approximate cost in different countries.

USA- $ 600,000-700,000 USD

China – $ 60,000-90,000 USD

India – $ 60,000-90,000 USD

Israel – $ 85,000-100,000 USD

Singapore – $ 700,000-750,000 SGD


In China, CAR T-cell therapy is primarily approved and used for the treatment of hematologic malignancies, such as lymphoma, leukemia, and myeloma.
While there are some clinical trials and research efforts exploring CAR T-cell therapy for solid tumors, progress in this area has been slower compared to hematologic malignancies.

As per the information available, CAR T-cell therapies for solid tumors account for only 9% of the total CAR T-cell therapies being developed in China.

The effectiveness of chimeric antigen receptor T-cell (CAR-T) therapy in China has been compared to alternative treatments through extensive clinical trials and research. As of 2022, China has a larger number of CAR-T clinical studies than the United States, particularly in hematologic malignancies. Two CAR-T therapies, axicabtagene ciloleucel (Yescarta) and relmacabtagene autoleucel (Carteyva), have been approved in China by the National Medical Products Administration (NMPA).

CAR-T therapy in China has demonstrated efficacy in various hematologic malignancies, including B-cell acute lymphoblastic leukemia (ALL), lymphoma, and multiple myeloma (MM). However, challenges remain, such as the high cost, time-consuming production process, and immune-related adverse events. To address these issues, Chinese researchers are developing strategies to optimize CAR-T therapy, including the development of allogeneic CAR-T products and the use of alternative costimulatory domains.

In summary, CAR-T therapy in China has shown promising results in hematologic malignancies, with a larger number of clinical trials compared to the United States. However, challenges remain, and further research is needed to optimize the therapy and expand its use to solid tumors.

Wholesale acquisitions of CAR-T cell therapies in China are generally around Chinese Yuan (CNY) 1,200,000, which is equivalent to approximately US$170,000. The cost-effectiveness of CAR-T cell therapies in China varies depending on the specific therapy and the patient’s condition. For example, the incremental cost-effectiveness ratio (ICER) for Axicabtagene ciloleucel (Axi-cel) versus standard of care (SOC) for patients with diffuse large B-cell lymphoma (DLBCL) in the second-line setting (2L) was approximately CNY 363,977 per quality-adjusted life year (QALY). However, these therapies are not considered cost-effective in any-line settings for DLBCL patients at the World Health Organization (WHO)-recommended willingness-to-pay threshold. Price reduction of CAR-T therapies is a main approach for lowering ICERs and ensuring that drug costs are proportional to patient health benefits.

Top Cancer Hospitals

Top Oncologists

Generic placeholder image
Dr. Erica L. Mayer

Boston, United States

Director, Clinical Research , Experience: 23
Generic placeholder image
Dr. Ang Peng Tiam


Medical Director and Senior Consultant Medical Oncology , Experience: 24 Years
Generic placeholder image
Prof. Peihua Peggy Lu

Beijing, China

Medical Executive President of Lu Daopei Hospital, Beijing, China , Experience: 27 Years
Generic placeholder image
Prof. Arnon Nagler

Tel Aviv, Israel

Director of the Division of Hematology , Experience: 34 Years

Latest in Cancer

Start chat
Need help with cancer treatment?
Scan the code
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy